Koers India Globalization Capital, Inc. Nyse
Aandelen
US45408X3089
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 1,24 mln. 1,16 mln. | Omzet 2025 * | 1,4 mln. 1,3 mln. | Marktkapitalisatie | 33,77 mln. 31,38 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -12 mln. -11,15 mln. | Nettowinst (verlies) 2025 * | -10 mln. -9,29 mln. | EV/omzet 2024 * | 27,2 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 24,1 x |
K/w-verhouding 2024 * |
-2,32
x | K/w-verhouding 2025 * |
-3,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 79,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29-04-05 |
Claudia Grimaldi
DFI | Director of Finance/CFO | 53 | 09-05-18 |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ram Mukunda
FOU | Founder | 65 | 29-04-05 |
Richard Prins
CHM | Chairman | 67 | 01-05-07 |
Director/Board Member | 79 | 18-01-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |